New imaging tools help cancer researchers see inside living cells

A new study co-led by an Oregon Health & Science University researcher describes a breakthrough in microscopy tools that ...

Revolving doors and efficient engines: How proteins escape a molecular tangle

Trying to untangle a knot in a mess of strings can be frustrating and time-consuming. But not so for molecular ...
Nature

Hidden human–virus interactions uncovered in DNA in blood and saliva

The abundance of viral DNA was measured in DNA sequenced from blood and saliva samples in biobanks, revealing strong correlations with age, sex and dozens of genetic variants. Genetic analyses ...
eLife

Prophylactic Lipoxin A

Methodology that is not complete, as well as discrepancies regarding the proposed mode of action of lipoxin A4, are significant weaknesses.
AHA/ASA Journals

Targeting Interleukin-8–Mediated Cellular Crosstalk Reverses Hypertrophic Cardiomyopathy and Cardiac Fibrosis in Noonan Syndrome

BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Science Daily

Our DNA is at risk of hacking, warn scientists

As many DNA datasets are openly accessible online, the study warns it is possible for cybercriminals to misuse the information for surveillance, manipulation, or malicious experimentation. Dr Anjum ...
Hosted on MSN

Intensity Therapeutics surges 395% on phase 1/2 data for solid tumors asset

Intensity Therapeutics (INTS), with a ~$13M market cap, closed up nearly 395% Thursday after publishing phase 1/2 results on its candidate for metastatic or refractory cancers, INT230-6. The asset ...